Clinical Trial Update: A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating HLX10 in combination with Carboplatin and Pemetrexed with or without HLX04 versus Carboplatin plus Pemetrexed in first-line advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• HLX04 (HLX04)
• HLX10
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: UNKNOWN